Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Fortschr Neurol Psychiatr ; 81(6): 337-45, 2013 Jun.
Article in German | MEDLINE | ID: mdl-23612984

ABSTRACT

We report upon a case of a 55 year old patient with a bipolar affective disorder, presenting herself with a depressive symptomatology in addition to a severe motor perturbation. The main emphasis upon admittance was perfecting and improving her latest medication. Four weeks prior to her stay at our clinic a thorough neurological examination had taken place in terms of an invalidity pension trial which did not result in any diagnostic findings. Therefore a neurological disease seemed at first highly unlikely. Even though the prior testing was negative, the ensuing neurological examination at our clinic resulted in movement disorders very much indicative of Huntington's Disease. A detailed investigation in regards to the particular family history of the patient was positive for Huntington's Disease. However, whether the patient's mother had also been a genetic carrier of Huntington's Disease was still unknown at the time the patient was admitted to our clinic. It was nevertheless discovered that her mother had also suffered from a bipolar affective disorder. A genetic testing that followed the neurological examination of the patient proved positive for Huntington's Disease. Neuro-imaging resulted in a bicaudate-index of 2.4 (the critical value is 1.8). In a clinical psychological test battery the ensuing results were highly uncommon for patients with solely a bipolar affective disorder people. Under the medical regimen of Quetiapine, Citalopram and Tiaprid the patient's mood could be stabilized and there was some improvement of her motor pertubation.


Subject(s)
Bipolar Disorder/complications , Huntington Disease/complications , Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Bipolar Disorder/diagnosis , Bipolar Disorder/psychology , Citalopram/therapeutic use , Dibenzothiazepines/therapeutic use , Female , Genetic Testing , Heterozygote , Humans , Huntington Disease/diagnosis , Huntington Disease/psychology , Magnetic Resonance Imaging , Middle Aged , Movement Disorders/etiology , Movement Disorders/therapy , Neurologic Examination , Neuropsychological Tests , Pedigree , Positron-Emission Tomography , Quetiapine Fumarate , Tiapride Hydrochloride/therapeutic use
2.
Psychol Med ; 37(12): 1717-29, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17506923

ABSTRACT

BACKGROUND: Although attention-deficit/hyperactivity disorder (ADHD) is thought to be an inhibitory disorder, the question remains of how specific the inhibitory deficit is in adults and whether it distinguishes ADHD from borderline personality disorder (BPD), with which it shares several clinical features, particularly impulsiveness. METHOD: The study assessed various motor and cognitive inhibitory functions (inhibition of prepotent, ongoing and interfering responses) in addition to working memory in adult ADHD patients with and without BPD, compared to subjects with BPD alone and controls. In addition, questionnaire data on various aspects of impulsiveness and anger regulation were assessed in all groups. RESULTS: ADHD patients performed worse than BPD individuals and controls in two inhibitory tasks: the stop signal task and the conflict module of the Attentional Network Task (ANT). In addition, they exhibited longer reaction times (RTs) and higher intra-individual variance in nearly all attentional tasks. The co-morbid group exhibited poor performance on the stop signal task but not on the conflict task. The BPD group barely differed from controls in neuropsychological performance but overlapped with ADHD in some behavioural problems, although they were less severe on the whole. CONCLUSIONS: Impaired inhibition is a core feature in adults with ADHD. In addition, slow RTs and high intra-individual variance in performance may reflect deficits in the regulation of activation and effort in ADHD patients. ADHD and BPD share some symptoms of behavioural dysregulation without common cognitive deficits, at least in the attentional realm.


Subject(s)
Attention Deficit Disorder with Hyperactivity/diagnosis , Borderline Personality Disorder/diagnosis , Inhibition, Psychological , Mental Disorders/diagnosis , Neuropsychological Tests , Adolescent , Adult , Anger , Attention , Attention Deficit Disorder with Hyperactivity/psychology , Borderline Personality Disorder/psychology , Comorbidity , Conflict, Psychological , Female , Humans , Impulsive Behavior/diagnosis , Impulsive Behavior/psychology , Male , Memory, Short-Term , Mental Disorders/psychology , Middle Aged , Neuropsychological Tests/statistics & numerical data , Psychometrics , Psychomotor Performance , Reaction Time
3.
Bipolar Disord ; 9(1-2): 63-70, 2007.
Article in English | MEDLINE | ID: mdl-17391351

ABSTRACT

OBJECTIVES: Elevated homocysteine (Hcy) levels have been demonstrated to have a negative impact on cognitive functioning in healthy elderly people. Further studies suggest that they are an independent risk factor for dementia, in particular for Alzheimer's disease. Bipolar disorder is also associated with cognitive impairment. However, the pathophysiological mechanisms of these deficits have not been elucidated yet. This study examines the role of Hcy on cognition and its impact on psychosocial functioning in euthymic bipolar patients. METHODS: A total of 55 euthymic bipolar patients and 17 healthy controls were enrolled in the study. Neuropsychological assessments consisted of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), the Trail Making Test (TMT), the Weschler Adult Intelligence Scale, 3(rd) edition (WAIS-III) subtest Letter-Number Sequencing Test (LNST) and the HAWIE-R (German version of the WAIS-R) subtest Information. Psychosocial functioning was assessed using the Social Adjustment Scale (SAS). To obtain plasma levels of Hcy, blood samples were collected in EDTA tubes, immediately put on ice, centrifuged within 15 min and stored at -80 degrees C. Total Hcy concentration was measured using high-performance liquid chromatography. RESULTS: In the neuropsychological tests, patients differed significantly from healthy controls on the TMT B and the RBANS composite indices Language, Attention and Total Score. No differences were found on the HAWIE-R subtest Information, the TMT A, LNST or the RBANS composite indices Immediate Memory, Visuospatial/Constructional Abilities and Delayed Memory. Mean Hcy levels were 9.8 +/- 3.2 microm/L in the patient group and 7.8 +/- 2.1 microm/L in the control group, respectively (p = 0.012). In the patient group Hcy levels significantly correlated with gender, diagnosis and RBANS index scores for Immediate Memory, Language, Attention and Total Score. Linear regression analyses revealed a significant and independent association of Hcy levels with Immediate Memory and TMT B scores in the patient group. Homocysteine levels did not correlate with any measure in the control group. Spearman's correlations indicated that psychosocial functioning in bipolar patients is not associated with clinical variables apart from time in remission. However, it correlated significantly with working memory measures (LNST). No relationship could be determined between psychosocial functioning and Hcy plasma levels. CONCLUSIONS: Elevated Hcy levels seem to be associated with cognitive impairment in euthymic bipolar patients, but not with psychosocial functioning. More studies are needed to clarify the role of Hcy in cognition in bipolar disorder.


Subject(s)
Bipolar Disorder/epidemiology , Cognition Disorders/blood , Cognition Disorders/epidemiology , Dysthymic Disorder/epidemiology , Hyperhomocysteinemia/blood , Hyperhomocysteinemia/epidemiology , Social Adjustment , Adult , Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Bipolar Disorder/diagnosis , Bipolar Disorder/drug therapy , Cognition Disorders/diagnosis , Cross-Sectional Studies , Diagnostic and Statistical Manual of Mental Disorders , Drug Therapy/statistics & numerical data , Dysthymic Disorder/diagnosis , Dysthymic Disorder/drug therapy , Female , Humans , Hyperhomocysteinemia/diagnosis , Male , Memory Disorders/diagnosis , Memory Disorders/epidemiology , Neuropsychological Tests , Psychology , Severity of Illness Index , Surveys and Questionnaires
4.
Br J Dermatol ; 156(4): 629-34, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17263822

ABSTRACT

BACKGROUND: Patients who suffer from chronic itch employ creative techniques to alleviate their itch, often using painful thermal stimuli, such as hot and very cold showers, as well as mechanical stimuli, such as scratching. OBJECTIVES: The present study examined whether the sensory perception of itch is attenuated by remote interactions between both thermal and mechanical stimuli and afferent information related to itch. PATIENTS AND METHODS: Itch was induced with histamine iontophoresis in 21 healthy young subjects. Repetitive thermal stimuli including innocuous warmth, innocuous cool, noxious cold and noxious heat as well as scratching were applied 3-cm distal to the area of histamine iontophoresis. Subjects rated their perceived intensity of histamine-induced itch with a computerized visual analogue scale. RESULTS: Itch intensity ratings were significantly reduced during each period of scratching and repeated noxious heat and cold. Innocuous cooling and warming did not significantly alter itch intensity ratings. Inter-individual differences in histamine-induced itch sensitivity were unrelated to inter-individual differences in pain sensitivity. CONCLUSIONS: The present psychophysical study demonstrates that repetitive noxious thermal and scratching stimuli inhibit itch and do not require direct physical interaction with the area of the skin from which itch originates.


Subject(s)
Hot Temperature/therapeutic use , Nociceptors/physiology , Pruritus/psychology , Skin Temperature/physiology , Thermosensing/physiology , Adult , Cryotherapy , Female , Humans , Male , Middle Aged , Pain Measurement , Perception/physiology , Pruritus/therapy , Psychophysics , Sensory Thresholds/physiology
5.
Neurology ; 62(8): 1378-83, 2004 Apr 27.
Article in English | MEDLINE | ID: mdl-15111677

ABSTRACT

OBJECTIVE: To determine if aging changes the frequency, severity, or manifestations of symptomatic distal sensory polyneuropathy (SxDSPN) in patients with HIV-1. METHODS: Prospective observations of 70 older (age < or = 50) and 56 younger (age 20 to 40) patients with HIV, and a control group of 48 older non-HIV patients, were conducted utilizing neurologic examination, neuropsychological testing, lumbar puncture, laboratory, and medical history. RESULTS: The frequency of SxDSPN among older HIV patients was 50.4%, compared to 19.6% among younger HIV patients (p < 0.001). SxDSPN among control patients occurred in 4.2%, similar to the general population. Older compared to younger HIV patients demonstrated more severe symptoms (p = 0.02) and greater deficits for vibration (p < 0.01). Increasing numbers of neuropathic comorbidities among older compared to younger HIV patients were associated with increasing severity of deficits to pinprick (p = 0.003). Dementia and SxDSPN coexisted in 36% of the older HIV patients and in none of the younger HIV patients (p = 0.021). Older HIV patients with nadir CD4 < or =200 cells/mL were 4.23 times as likely to have SxDSPN than older patients with nadir CD4 >200 cells/mL (p = 0.007). Vibratory deficits excessive to pinprick deficits predicted SxDSPN among older (OR 2.83) but not younger seropositive patients (p = 0.036). CONCLUSIONS: Age > or = 50 increases the frequency of SxDSPN, and is associated with both vibratory loss as the predominant sensory deficit and increased severity of pinprick loss among symptomatic patients with neuropathic comorbidities. SxDSPN is associated with both dementia and low nadir CD4 in HIV-positive patients aged 50 and greater.


Subject(s)
AIDS Dementia Complex/epidemiology , HIV Infections/epidemiology , HIV Seropositivity/epidemiology , HIV-1 , Polyneuropathies/epidemiology , AIDS Dementia Complex/immunology , AIDS Dementia Complex/virology , Adult , Age Distribution , Age Factors , Aged , Aging/immunology , CD4 Lymphocyte Count , Cohort Studies , Comorbidity , Cross-Sectional Studies , HIV Infections/immunology , HIV Infections/virology , HIV Seropositivity/immunology , HIV Seropositivity/virology , Hawaii/epidemiology , Humans , Longitudinal Studies , Middle Aged , Polyneuropathies/immunology , Polyneuropathies/virology , Prevalence , Prospective Studies , Severity of Illness Index
7.
Physiol Behav ; 69(1-2): 161-73, 2000.
Article in English | MEDLINE | ID: mdl-10854927

ABSTRACT

The study of genetic variation in taste produces parallels between mice and men. In mice, genetic variation across strains has been documented with psychophysical and anatomical measures as well as with recordings from whole nerves. In humans, the variation has been documented with psychophysical and anatomical measures. Whole-nerve recordings from animals and psychophysical ratings of perceived intensities from human subjects have a similar logical limitation: absolute comparisons across individuals require a standard stimulus that can be assumed equally intense to all. Comparisons across whole-nerve recordings are aided by single-fiber recordings. Comparisons across psychophysical ratings of perceived intensity have been aided by recent advances in methodology; these advances now reveal that the magnitude of genetic variation in human subjects is larger than previously suspected. In females, hormones further contribute to variation in taste. There is evidence that the ability to taste (particularly bitter) cycles with hormones in women of child-bearing age, rises to a maximum early in pregnancy and declines after menopause. Taste affects food preferences, which in turn affect dietary behavior and thus disease risks. Valid assessment of taste variation now permits measurement of the impact of taste variation on health. Advances in psychophysical methodology were essential to understanding genetic variation in taste. In turn, the association of perceived taste intensities with tongue anatomy now provides a new tool for psychophysics. The ability of a psychophysical scale to provide across-subject comparisons can be assessed through its ability to show the fungiform papillae density-taste association.


Subject(s)
Taste/genetics , Animals , Diet , Female , Humans , Mice , Pregnancy , Species Specificity , Taste/physiology
8.
Ann N Y Acad Sci ; 855: 793-6, 1998 Nov 30.
Article in English | MEDLINE | ID: mdl-9929686

ABSTRACT

Taste blindness to phenylthiocarbamide (PTC) and its chemical relative 6-n-propylthiouracil (PROP) was discovered in the 1930s. Family studies showed that those who could not taste PTC/PROP (nontasters) carried two recessive alleles. In recent years, we have classified tasters into two groups: medium (PROP is moderately bitter) and supertasters (PROP is intensely bitter). With our classification, approximately 25% of Americans are nontasters, 50%, medium tasters, and 25%, supertasters. Studies showed that supertasters form a cohesive group. Anatomical studies showed that supertasters have the most fungiform papillae. Psychophysical studies showed that supertasters perceive the most intense bitterness and sweetness from a variety of compounds, the most intense burn from oral irritants, and the most intense tactile sensations from viscous solutions. Oral burn and touch are presumably perceived to be the most intense to supertasters because taste buds in fungiform papillae are innervated by the trigeminal nerve (pain, touch) as well as the chorda tympani nerve (taste). The psychophysical scaling method used was magnitude matching with NaCl as the control modality. With this method, subjects rated the intensities of a series of NaCl and PROP solutions. The assumption that the taste of NaCl did not vary with PROP status allowed comparisons of the bitterness of PROP across subjects. Early magnitude matching studies, using sound as the control, had suggested that this assumption was reasonable. However, recent studies challenged that conclusion. Larger samples with more diverse populations, using sound as the control, showed that the taste of NaCl varied with PROP bitterness; supertasters perceived the strongest taste and nontasters, the weakest. Thus our earlier conclusions were conservative because differences between nontasters, medium tasters, and supertasters were concealed by using NaCl as a standard. Using magnitude matching with sound as the standard, or using the Green scale, which employs intensity labels, we found that the differences between PROP groups are larger. Note that the association between PROP status and salt taste is interesting in itself, since variability in salt taste may have important nutritional consequences.


Subject(s)
Taste Disorders , Humans , Propylthiouracil , Sodium Chloride , Taste Disorders/diagnosis , Taste Disorders/genetics , Taste Threshold
9.
Nervenarzt ; 66(9): 696-702, 1995 Sep.
Article in German | MEDLINE | ID: mdl-7477607

ABSTRACT

The usefulness of the multiple-choice word test (MWT-B) was tested as a measure for premorbid intelligence in 107 patients with probable Alzheimer's disease following the NINCDS-ADRDA criteria. The patients were allocated to three groups according to severity of dementia: mild (n = 40), moderate (n = 41) and severe (n = 26). Dementia severity was assessed with the Mini Mental State Test (MMST). The mean of the raw values of the MWT-B (maximum 37) in the group with mild dementia was 28.0 (SD = 5.57), in the group with moderate dementia 23.3 (SD = 8.01), and in the group with severe dementia 6.7 (SD = 8.44), indicating a parallel worsening with the other tests. The MWT-B value of the whole sample correlated with the MMST value (r = 0.70); a significant correlation still existed in patients with mild and moderate dementia. These results confirm that the MWT-B is relevant for dementia. The rate of cerebral glucose metabolism, measured with positron emission tomography (PET) and 18F-fluorodeoxy-glucose (FDG) correlated significantly with the MWT-B scores in the Alzheimer-sensitive temporoparietal region (r = 0.43; P = 0.001) and frontal brain region (r = 0.37; P < 0.05). Whether or not it can be used as a screening measure of dementia will have to be decided on the basis of its scales for sensitivity and specificity.


Subject(s)
Alzheimer Disease/diagnosis , Intelligence Tests/statistics & numerical data , Vocabulary , Aged , Aged, 80 and over , Alzheimer Disease/classification , Alzheimer Disease/physiopathology , Alzheimer Disease/psychology , Blood Glucose/metabolism , Brain/physiopathology , Humans , Mental Status Schedule/statistics & numerical data , Middle Aged , Psychometrics , Reproducibility of Results , Tomography, Emission-Computed
10.
Scand J Work Environ Health ; 11(5): 365-9, 1985 Oct.
Article in English | MEDLINE | ID: mdl-4071002

ABSTRACT

In a cohort study the incidence of skin tumors on the hands and forearms of 682 turners exposed to cutting oils was compared to the incidence of the general male population and of office workers. Among the 682 turners, five premalignant squamous cell tumors and eight keratoacanthomas were found between 1960 and 1980. Five of this total of 13 turners with primary skin tumors had another skin tumor as well. Among the 682 men there were four cases of scrotal cancer. Among the 375 office workers examined, no malignant or premalignant tumors or keratoacanthomas were found on the hands or forearms. No primary skin tumors were found among the turners after 1975, when the acid-refined mineral oils were replaced by solvent-refined oils containing a far lower concentration of polyaromatic hydrocarbons, which are probably the cancerogenic agent in the oils. The study shows a greatly increased risk of skin tumors on the hands and forearms of workers exposed to acid-refined mineral oils. Individual susceptibility also seems to be indicated.


Subject(s)
Keratoacanthoma/chemically induced , Mineral Oil/poisoning , Occupational Diseases/chemically induced , Precancerous Conditions/chemically induced , Skin Diseases/chemically induced , Skin Neoplasms/chemically induced , Adult , Aged , Forearm , Hand , Humans , Male , Middle Aged , Risk
SELECTION OF CITATIONS
SEARCH DETAIL
...